Real world study for the concordance between IBM Watson for Oncology and clinical practice in advanced non‐small cell lung cancer patients at a lung cancer center in China

BACKGROUND: IBM Watson for Oncology (WFO) provides physicians with evidence‐based treatment options. This study was designed to explore the concordance of the suggested therapeutic regimen for advanced non‐small cell lung (NSCLC) cancer patients between the updated version of WFO and physicians in o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Shuyang, Wang, Ruotian, Qian, Kun, Zhang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180560/
https://www.ncbi.nlm.nih.gov/pubmed/32191394
http://dx.doi.org/10.1111/1759-7714.13391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180560/
https://www.ncbi.nlm.nih.gov/pubmed/32191394
http://dx.doi.org/10.1111/1759-7714.13391

Ejemplares similares